Skin Graft Market Summary
As per MRFR Analysis, the Global Skin Graft Market was valued at 4.58 USD Billion in 2024 and is projected to grow to 9.02 USD Billion by 2034, with a CAGR of 7.01% from 2025 to 2034. The market is driven by the increasing incidence of skin burns and surgeries, alongside rising skin cancer cases and diabetes prevalence, which necessitate skin grafts for effective treatment.
Key Market Trends & Highlights
The skin graft market is witnessing significant growth due to various health trends.
- Skin cancer cases in the UK are rising, with 42 new melanoma cases reported daily.
- The autologous graft segment accounted for 40.6% of market revenue in 2022.
- The burns segment dominated the market, driven by high injury frequency and patient awareness.
- The Asia-Pacific region is expected to grow at the fastest CAGR from 2023 to 2032 due to increasing burn cases.
Market Size & Forecast
2024 Market Size: USD 4.58 Billion
2034 Market Size: USD 9.02 Billion
CAGR (2025-2034): 7.01%
Largest Regional Market Share in 2024: North America
Major Players
Key players include Avita Medical, Zimmer Biomet, Medtronic, Stratatech Corp, and Specimen Medical.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Skin Graft Market Trends
- Rising prevalence of skin cancer is driving the market growth
Market CAGR for skin grafts is driven by the rising cases of skin cancer. In the best-case scenario, skin transplants are desired after skin cancer surgery. Skin grafts are typically referred for local postoperative radiotherapy (PORT) to guarantee that the surgical bed produced during radiotherapy is closed. According to Cancer Research UK, 42 new cases of melanoma skin cancer are reported in the UK each day, totaling around 15,400 new cases per year. Between 2014 and 2035, the UK's melanoma skin cancer incidence rate is expected to increase by 7%, reaching 32 incidences per 100,000 persons. Rising UV exposure among the population is projected to increase with rising warming, contributing to an increase in skin cancer worldwide.
One of the most widespread medical disorders in the world is diabetes. In 2019, 463 million adults worldwide had diabetes, according to the International Diabetes Federation's (IDF) IDF Diabetes Atlas Ninth Edition. By 2045, it is assumed that 700 million adults worldwide—or about 79% of those in low- and middle-income countries—will live with diabetes. Diabetes patients' wounds take longer to heal, which raises the risk of skin infections if they are not treated in a specific amount of time. Approximately 25% of diabetic people will likely experience foot ulcers at some point, frequently requiring advanced diabetic wound care. Due to the reduced risk of skin infections, the need for skin grafts to treat or hide diabetic foot sores is rising. Thus, it is anticipated that the increased prevalence of diabetes and skin cancer will propel the skin graft market in the near future. Thus, driving the skin graft market revenue.
Skin Graft Market Segment Insights
Skin Graft Insights
The skin graft market segmentation, based on graft, includes isogeneic, autologous, allogeneic, xenogeneic, and prosthetic. The autologous segment dominated the market, accounting for 40.6% of market revenue (1.6 Billion). The sector for autologous grafting is anticipated to expand significantly due to increasing demand for non-invasive aesthetic procedures for skin rejuvenation. The numerous benefits of fat grafting operations, such as quick recovery with fewer allergy hazards and shorter downtime, are also causing the sector to grow. Additionally, the prosthetic graft sector witnessed the fastest growth rate in 2022. The increased demand for prosthetic skin results from rising awareness of various skin care treatments.
Figure 1: Skin Graft Market, by Graft, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Skin Graft Application Insights
The skin graft market segmentation, based on application, includes extensive wounds, burns, extensive skin loss due to infection, skin cancers, and others. The burns segment dominated the market. The increased frequency of these injuries, high demand for skin grafts, increased patient awareness of available treatments, and technical advancements primarily drive the expansion of the burns segment. Furthermore, the skin cancer sector is predicted to grow at a considerable CAGR during the forecast period. Rising UV exposure among the population is projected to increase with rising warming, contributing to an increase in skin cancer worldwide.
Skin Graft Type Insights
The skin graft market segmentation, based on graft type, includes split-thickness, full-thickness, and composite graft. In 2022, full-thickness category dominated the market. Full-thickness skin grafts have the advantages of not changing the recipient site's architecture and being very simple for both the patient and the physician. However, the composite graft segment showed a significant growth rate. Composite grafts can also fill partial-thickness defects that are too deep for an FTSG to cure without leaving a concave defect or contracting the free margin.
Skin Graft Equipment Insights
The skin graft market segmentation, based on equipment, includes dermatomes (knives dermatomes, drum dermatomes, electric dermatomes, air dermatomes), general surgical instruments, consumables and others. Dermatome device improvements are anticipated to continue enhancing outcomes while maintaining high accuracy and precision during the projection period. In 2022, the electric dermatome device market segment held a commanding. The powered dermatomes are a popular option for many surgeons because they offer constant, dependable skin grafts and are simple to use. The sector for skin consumables will grow due to developments in medical technology, increased public and private groups' efforts to raise awareness of the disease, and rising government support.
September 2022:Bristol-Myers Squibb said that the FDA had approved SotyktuTM (deucravacitinib), a first-in-class, allosteric tyrosine kinase 2 (TYK2) inhibitor, selective and oral, for the medical management of people with moderate-to-severe plaque psoriasis who are not suitable for systemic therapy or phototherapy.1,2Sotyktu should not be used with other powerful immunosuppressants.
Skin Graft End-User Insights
The skin graft market segmentation, based on end-user, includes hospitals and clinics, academic and research, and others. In 2022, the hospitals and clinics segment dominated the market. The fact that the patient is typically brought to the hospital in most trauma or burn situations explains the large share of this sector. Over the projected period, the category of ambulatory surgery centers is anticipated to increase at the fastest rate. This is partly because ambulatory surgical centers perform more aesthetic or cosmetic operations.
Skin Graft Regional Insights
By region, the study provides market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American skin graft market area will dominate this market. The growing demand for skin grafts and substitutes and the rising number of burn injuries are the main drivers propelling the market expansion in North America. Additionally, the presence of significant market participants in this industry who are committed to strategic initiatives, such as the launch of novel products and acquisitions and mergers, is projected to create prospects for lucrative expansion.
Further, the major countries studied in the market report are US, Canada, France, German, Italy, UK, Spain, Japan, China, Australia, India, South Korea, and Brazil.
Figure 2: SKIN GRAFT MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe’s skin graft market accounts for the second-largest market share. Teenagers are more inclined to suffer from acne and other skin issues, which is assisting the growth of the European market. For instance, the U.K. National Health Service (NHS) reports that acne is very typical among teenagers and young adults. 95% of people in the country between the ages of 11 and 30 have acne. Further, the German skin graft market held the largest market share, and the UK skin graft market was the rapidly-growing market in the European region.
The Asia-Pacific Skin Graft Market is expected to grow at the fastest CAGR from 2023 to 2032. The increase in burn cases in developing nations like India, Malaysia, and Indonesia is to blame for this. According to a study, South and South-East Asia will have the highest burden in 2022, accounting for 30–40% of all burn cases worldwide. Moreover, China’s skin graft market held the largest market share, and the Indian skin graft market was the rapidly-growing market in the Asia-Pacific region.
Skin Graft Key Market Players & Competitive Insights
Leading market players are largely investing in R&D to expand their production capacities, which will aid in the further expansion of the chemotherapy industry. The launch of new products, larger-scale mergers and acquisitions, contractual agreements, and collaboration with other organizations are significant market developments in which market participants engage to increase their presence. The skin graft industry must provide affordable products to expand and thrive in a more competitive and challenging market environment.
One of the major business strategies manufacturers use in the skin graft industry to increase the market sector and benefit customers are local manufacturing to lower operational costs. Recently, the skin graft industry has stipulated some of the most important medicinal benefits. Major players in the skin graft market, including Avita Medical, Zimmer Biomet, Medtronic, Stratatech Corp, Specimen Medical, and others, are funding operations for research and development to boost market demand.
Stratatech is a company developing a genetically altered human skin substitute to prevent skin wounds. The company's replacement is constructed of human cells that operate as a temporary wound cover, combating bacterial infections and promoting healing by a patient's cells, allowing patients to receive therapy for chronic, non-healing wounds readily. In June 2021, Mallinckrodt's Stratatech got FDA approval today for their StrataGraft treatment for adult patients suffering from thermal burns. StrataGraft was developed by the Bedminister, New Jersey-based business to treat thermal burns with intact dermal elements or remaining deep skin layers, for which surgical intervention is clinically necessary.
Kinetic Concepts, Inc. (KCI) is a multinational firm that develops medical technologies for wounds and wound healing. Its headquarters are located in San Antonio, Texas. KCI comprises three business segments that serve the markets for therapeutic support systems, regenerative medicine, and wound care: Active Healing Solutions, LifeCell, and Therapeutic Support Systems. In December 2021, Kinetic Concepts, Inc. today announced the completion of its acquisition of MoMelan Technologies, Inc., a privately held medical technology business that develops revolutionary skin grafting solutions. The transaction's terms were not disclosed. MoMelan created a novel epidermal grafting solution that uses donor site-sparing technology to enable and standardize epidermal skin grafting in the office or outpatient scenario with minimum discomfort.
Key Companies in the skin graft market include
Skin Graft Industry Developments
November 2022:AVITA Medical, Inc., a regenerative medicine company that develops and commercializes first-in-class equipment and autologous cellular treatments for skin restoration, announced today that the FDA had designated the RECELL System as a Breakthrough Device for both its pitched soft tissue repair indication and its vitiligo indication.
July 2020:Lancer Skincare has announced the release of its first skincare exfoliation equipment, the Pro Polish Microdermabrasion equipment, which is presently available exclusively on QVC. The launch of the Pro Polish Microdermabrasion Device draws on Dr. Harold Lancer's 30 years of dermatology invention, research and practice and marks Lancer Skincare's entry into a new cosmetic market.
Skin Graft Market Segmentation
Skin Graft Graft Outlook
Skin Graft Graft Thickness Outlook
Skin Graft Application Outlook
- Extensive Skin Loss Due To Infection
Skin Graft Equipment Outlook
- General Surgical Instruments
Skin Graft End-User Outlook
Skin Graft Regional Outlook
| Attribute/Metric |
Details |
|
Market Size 2024
|
  4.58 (USD Billion)
|
|
Market Size 2025
|
  4.90 (USD Billion)
|
|
Market Size 2034
|
  9.02 (USD Billion)
|
|
Compound Annual Growth Rate (CAGR)
|
  7.01 % (2025 - 2034)
|
|
Report Coverage
|
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
|
|
Base Year
|
2024
|
|
Market Forecast Period
|
2025 - 2034
|
|
Historical Data
|
2020 - 2024
|
| Report Coverage |
Market Competitive Landscape, Growth Factors, Revenue Forecast, and Trends |
| Segments Covered |
Graft, Graft Thickness, Application, Equipment, and End-User |
| Geographies Covered |
North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered |
US, Canada, France, German, Italy, UK, Spain, Japan, China, Australia, India, South Korea, and Brazil. |
| Key Companies Profiled |
Avita Medical, Zimmer Biomet, Medrotonic, Stratatech Corp, and Specimen Medical. |
| Key Market Opportunities |
3D-printed skin grafts |
| Key Market Dynamics |
An increasing number of burn injuries |
Skin Graft Market Highlights:
Frequently Asked Questions (FAQ) :
The market size of the skin graft market was prized at USD 4.00 Billion in 2022.
From 2023 to 2034, the anticipated CAGR for the market is 7.01 %.
The major portion of the market was accounted for by North America.
The notable players in the market are Avita Medical, Zimmer Biomet, Medtronic, Stratatech Corp, and Specimen Medical.
The autologous category dominated the market in 2022.
The burns wound type application had the largest share in the market.
